XORTX Therapeutics Inc.
CSE Index:
Currency:
XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease. Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease. Additional information on XORTX Therapeutics is available at www.XORTX.com.
XORTX Therapeutics Inc. (XRX)
SEDAR Information
Company Info
Address
Suite 2400 - 745 Thurlow Street
Vancouver, BC V6E 0C5
CanadaPhone
(403) 607-2621Email
adavidoff@xortx.comListing date
Wednesday, September 30, 2015Transfer Agent
TSX Trust CompanyAuditor
Morgan & Company LLP Capitalization
Issued & Outstanding:
62,919,691Reserved for Issuance:
6,428,740Company Officers
Allen Davidoff, President and Chief Executive Officer
James Fairbairn, Chief Financial Officer
Charlotte May, Corporate Secretary
W. Bruce Rowlands, Chairman
Paul J. Van Damme, Director
Alan W. Williams, Director
Bruce Cousins, Director
News Releases
Bulletins
10/01/2018
2018-0111 – Fundamental Change – APAC Resources Inc./XORTX Therapeutics Inc.
Le 10 janvier/January 2018
XORTX Therapeutics Inc., the issuer resulting from a Fundamental Change of APAC Resources Inc. has been approved for listing.
Advertisement
Publicité
